SLE vs CPB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 13, 2026

SLE

36.3
AI Score
VS
CPB Wins

CPB

43.4
AI Score

Investment Advisor Scores

SLE

36score
Recommendation
SELL

CPB

43score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric SLE CPB Winner
Revenue 1.87M 7.61B CPB
Net Income -6.65M 463.00M CPB
Net Margin -355.3% 6.1% CPB
Operating Income -10.94M 848.00M CPB
ROE -6.7% 11.5% CPB
ROA -6.6% 3.1% CPB
Total Assets 101.50M 15.14B CPB
Cash 31.45M 402.00M CPB
Current Ratio 11.55 0.87 SLE
Free Cash Flow -9.94M 542.00M CPB

Relative Price Performance (Last 90 Days)

SLE 1M: +45.3% · 3M: +48.8% CPB 1M: -7.1% · 3M: -7.6%

Current Technical Phase

SLE

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.4% over 20 days), RSI 64

RSI (14): 63.8 · Price: $4.91

CPB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 35

RSI (14): 35.4 · Price: $21.00

Fundamentals Snapshot

Metric SLE CPB
Market Cap
Forward P/E -1.6 11.0
Trailing P/E 0.0 16.8
Revenue (TTM)
Revenue Growth 0.0% -0.1%
Gross Margin 0.4% 0.3%
Operating Margin -1.2% 0.1%
EPS 114.77 1.25
Dividend Yield 0.07%

Frequently Asked Questions

Based on our detailed analysis, CPB is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.